Posted in Market

Merck’s Bio-Techne buyout put Life Sciences sector in focus: Top quant-rated stocks

Reporter


Jun 25, 2026, 1:28 PM ETState Street Health Care Select Sector SPDR ETF (XLV), VHT, IYH, XHE, IHI, IDNA, PBE, XBIDHR, ILMN, WST, WAT, TECH, PACB, MKGAF, MKKGY, SP500, PSNL, TXG, MRVI, ABCL, FTRE, HOLDBy: Sara Sethiya, SA News Editor
Health insurance and financial assurance concept with hospital investment as future asset advantage for medical security, growth, and strategic decision planning.

Father-Studio/iStock via Getty Images

The life sciences tools and services sector is back in focus after Merck KGaA (MKGAF) agreed to acquire Bio-Techne (TECH) for $73 per share in cash, valuing the deal at an enterprise value of around $11.3B (€9.9B).

The offer is



Source link

You May Also Like

These People HATED The Books Based On Their Real Lives

Alexis Wilkins, Girlfriend of Kash Patel, Slammed For ‘Murdering’ National Anthem at America 250 Event

Leave a Reply

Your email address will not be published. Required fields are marked *